| 001 | 990665 | ||
| 005 | 20251016075002.0 | ||
| 024 | 7 | _ | |2 ISSN |a 1663-9812 |
| 024 | 7 | _ | |2 SCOPUS |a SCOPUS:2-s2.0-85201717612 |
| 024 | 7 | _ | |2 WOS |a WOS:001294997100001 |
| 024 | 7 | _ | |2 doi |a 10.3389/fphar.2024.1412169 |
| 024 | 7 | _ | |2 pmid |a pmid:39175545 |
| 024 | 7 | _ | |2 datacite_doi |a 10.18154/RWTH-2024-07490 |
| 037 | _ | _ | |a RWTH-2024-07490 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Katahira, Shintaro |b 0 |
| 245 | _ | _ | |a Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model |h online |
| 260 | _ | _ | |a Lausanne |b Frontiers Media |c 2024 |
| 300 | _ | _ | |a 1-15 |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 536 | _ | _ | |0 G:(DE-82)021000-OAPKF |a OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF) |c 021000-OAPKF |x 0 |
| 536 | _ | _ | |0 G:(GEPRIS)322900939 |a DFG project G:(GEPRIS)322900939 - TRR 219: Mechanismen kardiovaskulärer Komplikationen bei chronischer Niereninsuffizienz (322900939) |c 322900939 |x 1 |
| 536 | _ | _ | |0 G:(GEPRIS)396654489 |a DFG project G:(GEPRIS)396654489 - Charakterisierung und Validierung von Mediatoren, die den Myokardinfarkt und die vaskuläre Verkalkung bei CKD beeinflussen (C04) (396654489) |c 396654489 |x 2 |
| 536 | _ | _ | |0 G:(GEPRIS)396660364 |a DFG project G:(GEPRIS)396660364 - Massenspektrometrie zur Identifizierung, Quantifizierung und Lokalisierung neuartiger Regula-toren von pathologischen Prozessen, die der CKD-assoziierten CVD zugrunde liegen (S03) (396660364) |c 396660364 |x 3 |
| 536 | _ | _ | |0 G:(GEPRIS)396658167 |a DFG project G:(GEPRIS)396658167 - Modulatorische Effekte der SGLT2-Inhibition auf den kardialen Stoffwechsel bei CKD-Patienten (M03) (396658167) |c 396658167 |x 4 |
| 536 | _ | _ | |0 G:(GEPRIS)396659311 |a DFG project G:(GEPRIS)396659311 - Erhöhtes Thromboserisiko und myokardiale Dysfunktion nach Myokardinfarkt bei CKD (M05) (396659311) |c 396659311 |x 5 |
| 536 | _ | _ | |0 G:(GEPRIS)498824272 |a DFG project G:(GEPRIS)498824272 - Einfluss des Peroxisome-Proliferator-Activated-Receptor-γ (PPARγ)-Signalwegs auf die Degeneration biologischer kardiovaskulärer Prothesen im Kontext eines relativen Östrogenmangels bei weiblichen Aortenklappenprothesenempfängerinnen (498824272) |c 498824272 |x 6 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de |
| 591 | _ | _ | |a Germany |
| 591 | _ | _ | |a Japan |
| 700 | 1 | _ | |0 P:(DE-82)IDM06953 |a Barth, Mareike |b 1 |e Corresponding author |u rwth |
| 700 | 1 | _ | |a Döpp, Robin |b 2 |
| 700 | 1 | _ | |a Sugimura, Yukiharu |b 3 |
| 700 | 1 | _ | |a Schmidt, Vera |b 4 |
| 700 | 1 | _ | |a Selig, Jessica Isabel |b 5 |
| 700 | 1 | _ | |a Saiki, Yoshikatsu |b 6 |
| 700 | 1 | _ | |0 P:(DE-82)IDM05899 |a Jankowski, Joachim |b 7 |u rwth |
| 700 | 1 | _ | |0 P:(DE-82)IDM00317 |a Marx, Nikolaus |b 8 |u rwth |
| 700 | 1 | _ | |0 P:(DE-82)IDM02912 |a Jahnen-Dechent, Wilhelm |b 9 |u rwth |
| 700 | 1 | _ | |a Lichtenberg, Artur |b 10 |
| 700 | 1 | _ | |a Akhyari, Payam |b 11 |
| 773 | _ | _ | |0 PERI:(DE-600)2587355-6 |a 10.3389/fphar.2024.1412169 |p 1412169 |t Frontiers in pharmacology |v 15 |x 1663-9812 |y 2024 |
| 856 | 4 | _ | |u https://publications.rwth-aachen.de/record/990665/files/990665.pdf |y OpenAccess |
| 876 | 7 | _ | |c 2733.68 |d 2024-08-09 |e APC |j Zahlung erfolgt |v 519.40 |x 021000-936710 |
| 909 | C | O | |o oai:publications.rwth-aachen.de:990665 |p dnbdelivery |p openCost |p VDB |p driver |p openaire |p open_access |p OpenAPC |
| 910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM06953 |a RWTH Aachen |b 1 |k RWTH |
| 910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM05899 |a RWTH Aachen |b 7 |k RWTH |
| 910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM00317 |a RWTH Aachen |b 8 |k RWTH |
| 910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM02912 |a RWTH Aachen |b 9 |k RWTH |
| 914 | 1 | _ | |y 2024 |
| 915 | 1 | _ | |0 StatID:(DE-HGF)0031 |2 StatID |a Peer reviewed article |x 0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1190 |2 StatID |a DBCoverage |b Biological Abstracts |d 2023-10-26 |
| 915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b FRONT PHARMACOL : 2022 |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0501 |2 StatID |a DBCoverage |b DOAJ Seal |d 2021-05-11T14:28:21Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |d 2021-05-11T14:28:21Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0700 |2 StatID |a Fees |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
| 915 | _ | _ | |0 StatID:(DE-HGF)1110 |2 StatID |a DBCoverage |b Current Contents - Clinical Medicine |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b DOAJ : Anonymous peer review |d 2021-05-11T14:28:21Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0561 |2 StatID |a Article Processing Charges |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)9905 |2 StatID |a IF >= 5 |b FRONT PHARMACOL : 2022 |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0320 |2 StatID |a DBCoverage |b PubMed Central |d 2023-10-26 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2023-10-26 |
| 915 | p | c | |0 PC:(DE-HGF)0000 |2 APC |a APC keys set |
| 915 | p | c | |0 PC:(DE-HGF)0001 |2 APC |a Local Funding |
| 915 | p | c | |0 PC:(DE-HGF)0002 |2 APC |a DFG OA Publikationskosten |
| 915 | p | c | |0 PC:(DE-HGF)0003 |2 APC |a DOAJ Journal |
| 920 | 1 | _ | |0 I:(DE-82)533540-2_20140620 |k 533540-2 ; 936710 |l Klinik und Lehrstuhl für Herzchirurgie |x 0 |
| 920 | 1 | _ | |0 I:(DE-82)531010-3_20140620 |k 932310 |l Institut und Lehrstuhl für Molekulare Herz-Kreislaufforschung |x 1 |
| 920 | 1 | _ | |0 I:(DE-82)531010-2_20140620 |k 932110 |l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Kardiologie und Pneumologie) |x 2 |
| 920 | 1 | _ | |0 I:(DE-82)029000_20200506 |k 029000 |l Helmholtz-Institut für Biomedizinische Technik |x 3 |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a APC |
| 980 | _ | _ | |a I:(DE-82)029000_20200506 |
| 980 | _ | _ | |a I:(DE-82)531010-2_20140620 |
| 980 | _ | _ | |a I:(DE-82)531010-3_20140620 |
| 980 | _ | _ | |a I:(DE-82)533540-2_20140620 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a journal |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|